Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 761

    1.

    Primary prevention of cardiovascular disease in people with dysglycemia.

    Bianchi C, Miccoli R, Penno G, Del Prato S.

    Diabetes Care. 2008 Feb;31 Suppl 2:S208-14. Review.PMID: 18227487 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

    Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group.

    JAMA. 2003 Jul 23;290(4):486-94.PMID: 12876091 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.

    Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M.

    Diabetes Care. 2008 Feb;31 Suppl 2:S155-60. Review.PMID: 18227478 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus.

    Delorme S, Chiasson JL.

    Curr Opin Pharmacol. 2005 Apr;5(2):184-9. Review.PMID: 15780829 [PubMed - indexed for MEDLINE]Related articles

    5.

    Heart disease in diabetic patients.

    Blendea MC, McFarlane SI, Isenovic ER, Gick G, Sowers JR.

    Curr Diab Rep. 2003 Jun;3(3):223-9. Review.PMID: 12762970 [PubMed - indexed for MEDLINE]Related articles

    6.

    Multifactorial aspects of the treatment of the type II diabetic patient.

    Colwell JA.

    Metabolism. 1997 Dec;46(12 Suppl 1):1-4. Review.PMID: 9439550 [PubMed - indexed for MEDLINE]Related articles

    7.

    Molecular mechanisms of diabetic cardiovascular disease.

    Hupfeld CJ, Wong GA.

    Prev Cardiol. 2002 Fall;5(4):183-7. Review.PMID: 12417827 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation]

    Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian. PMID: 18773746 [PubMed - indexed for MEDLINE]Related articles

    9.

    Hyperglycemia and cardiovascular disease in type 2 diabetes.

    Laakso M.

    Diabetes. 1999 May;48(5):937-42. Review.PMID: 10331395 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Cardiovascular mortality and morbidity in type-2 diabetes mellitus.

    Schernthaner G.

    Diabetes Res Clin Pract. 1996 Jul;31 Suppl:S3-13.PMID: 8864635 [PubMed - indexed for MEDLINE]Related articles

    11.

    [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?]

    Dussol B, Berland Y.

    Nephrol Ther. 2006 May;2(2):51-74. Epub 2006 Mar 9. Review. French. PMID: 16895717 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Prevention of cardiovascular disease in type 2 diabetes]

    Paquot N, Scheen AJ.

    Rev Med Liege. 2003 May;58(5):271-4. Review. French. PMID: 12940113 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Epidemiology of macroangiopathy in diabetes, including international comparisons]

    Nishimura R.

    Nippon Rinsho. 2006 Nov;64(11):2012-8. Review. Japanese. PMID: 17087291 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pharmacotherapy of diabetes mellitus: implications for the prevention and treatment of cardiovascular disease.

    Ragucci E, Zonszein J, Frishman WH.

    Heart Dis. 2003 Jan-Feb;5(1):18-33. Review.PMID: 12549986 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.

    Mazzone T.

    Am J Med. 2007 Sep;120(9 Suppl 2):S26-32.PMID: 17826043 [PubMed - indexed for MEDLINE]Related articles

    16.

    How to ADVANCE prevention of cardiovascular complications in type 2 diabetes.

    Grobbee DE.

    Metabolism. 2003 Aug;52(8 Suppl 1):24-8. Review.PMID: 12939736 [PubMed - indexed for MEDLINE]Related articles

    17.

    Clinicians can help their patients control postprandial hyperglycemia as a means of reducing cardiovascular risk.

    Gerich JE.

    Diabetes Educ. 2006 Jul-Aug;32(4):513-4, 520-2.PMID: 16873589 [PubMed - indexed for MEDLINE]Related articles

    18.

    Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes.

    Hu G; DECODE Study Group.

    Diabetologia. 2003 May;46(5):608-17. Epub 2003 May 15.PMID: 12750769 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Risk management of coronary heart disease-prevention]

    Dorner T, Rieder A.

    Wien Med Wochenschr. 2004 Jun;154(11-12):257-65. German. PMID: 15287702 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Type 2 diabetes mellitus and coronary heart disease]

    Brändle M, Amann FW, Salomon F.

    Schweiz Med Wochenschr. 1999 May 8;129(18):700-6. Review. German. PMID: 10407943 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data